For centuries, herbal medicine and holistic well-being treatments have played a key part in Japanese healthcare. Today, as the world faces acute medical concerns such as viral diseases and an aging society, a Japanese pharmaceutical firm specializing in throat medicine, Ryukakusan Co., Ltd., is bringing the best of these traditional products to a modern customer base.
With the increasing cost of medical care in Japan, the firm’s president, Ryuta Fujii, feels the need to promote people taking responsibility for their own health. “The greatest feature of the Japanese healthcare system is the high quality of the medical insurance system. In the future, we need to encourage more people to look for ways to help themselves before visiting a medical professional so that we can leave this wonderful system to the next generation. Let’s take responsibility for our own health and treat minor physical ailments by ourselves,” said Fujii.
Ryukakusan Direct – This product is classified as an over-the-counter drug in Japan.
The company’s products support health and wellness, with particular effectiveness in helping people affected by sore throats. It hopes to position its remedies as a key part of people improving their own health. “The type of drug that is absorbed through the gastrointestinal tract to exert its effects has much greater potential for side effects in different regions of the body. Our main products, Ryukakusan and Ryukakusan Direct, are powders that act directly on the mucous membrane of the throat. Because of its local action, we have heard reports of pregnant women being recommended Ryukakusan by their gynecologists. Furthermore, Ryukakusan Direct is individually packaged, making it portable and useful in any situation for someone dealing with throat issues,” said Fujii. The company’s products can be used as part of a daily regimen. The firm combines herbal ingredients with modern manufacturing standards and keenly embraces innovation. Other than the Ryukakusan and Ryukakusan Direct Series, innovations also include the development of a jelly to assist people with weak swallowing ability to take medicine. This is especially important for an aging society and was developed based on the company’s knowledge of life and conditions in nursing care.
“If we create a product that is beneficial to society, the profits will follow.” ーRyuta Fujii, President, Ryukakusan Co., Ltd.
Ryukakusan – This product is classified as an over-the-counter drug in Japan.
Given that COVID-19 still remains a concern, the company’s Ryukakusan and Ryukakusan Direct products, with their direct-to-the-throat effects, are popular among people of all ages. The business is now working to raise its profile and expand its sales in neighboring markets such as China, while also boosting supply to meet demand. “We are prepared to expand wherever our products are needed,” said Fujii. With a keen sense of social responsibility, the president confirmed that the main priorities for the company are public health and social benefits. “The most important issue for us is not whether a product will be profitable, but rather will our customers gain better health because of it. We believe that if we create a product that is beneficial to society, then the profits will follow,” said Fujii.
